Actively Recruiting
Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-07-03
2250
Participants Needed
1
Research Sites
469 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
I
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this work is to identify, in patients with autoimmune diseases, systemic vasculitis and autoinflammatory disease, cytokine and lymphocyte biomarkers of activity of these diseases to identify follow-up biomarkers, in order to personalize the follow-up and the treatments for each patient. Immunological data will be obtained from biological samples collected as part of the usual patient care pathway (Blood and tissues sampling) The study will take place in the Department of Internal Medicine and Clinical Immunology (DMIIC), that is certified as the National Reference Centre for Rare Systemic Autoimmune Diseases and the National Reference Centre for Inflammatory Autoinflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA). Its objective is to contribute to the advancement of fundamental knowledge in immunology, in particular to develop prognostic biomarkers of the activity of autoimmune diseases, systemic vasculitis and autoinflammatory diseases by using blood tests.
CONDITIONS
Official Title
Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of 18 years of age or older
- Diagnosis of autoimmune systemic disease, systemic vasculitis, or autoinflammatory disease according to international criteria
- Includes conditions such as lupus, Sj�f6gren syndrome, antiphospholipid syndrome, mixed connectivity and Sharp syndrome, scleroderma, myositis
- Includes vasculitis of large, small, and medium vessels such as giant cell arteritis, Takayasu arteritis, Beh�e7et disease, ANCA vasculitis, cryoglobulinemic vasculitis, IgA vasculitis
- Includes Buerger's disease (obliterating thromboangitis), granulomatosis, sarcoidosis, uveitis
- Includes monogenic and polygenic autoinflammatory diseases such as familial Mediterranean fever, TRAPS, CAPS, chronic atrophic polychondritis, pericarditis
- Includes recurrent fevers and unexplained inflammatory syndromes
- Includes inflammatory amyloidosis
- Patients affiliated to French social security
You will not qualify if you...
- Persons deprived of liberty by judicial or administrative decision
- Persons receiving psychiatric care without their consent
- Adults subject to legal protection measures such as guardianship or curatorship
- Persons unable to give their consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Département de Médecine Interne et Immunologie Clinique (DMIIC), Hôpital Pitié-Salpêtrière
Paris, France, France, 75013
Actively Recruiting
Research Team
D
David Saadoun, Professor
CONTACT
N
Nassima Mansour
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here